V

Vaxart
D

VXRT

0.38200
USD
0.03
(7.58%)
مغلق
حجم التداول
30,411
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
87,076,612
أصول ذات صلة
BNTX
BNTX
-1.420
(-1.52%)
91.890 USD
I
INO
-0.06500
(-3.93%)
1.59000 USD
MRNA
MRNA
-2.020
(-7.29%)
25.700 USD
N
NVAX
-0.38500
(-6.44%)
5.59500 USD
PFE
PFE
-0.385
(-1.56%)
24.290 USD
المزيد
الأخبار المقالات

العنوان: Vaxart

القطاع: Healthcare
الصناعة: Biotechnology
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.